- Actinium Pharmaceuticals是一家专注于开发针对癌症的放射性同位素治疗药物的生物制药公司,致力于为急性髓细胞性白血病(AML)患者开发靶向治疗肿瘤的创新疗法。
- 其放射性药物 Iomab-B 的三期 SIERRA 试验的积极数据显示,复发/难治性急性髓细胞白血病患者的生存率提高。
...查看全文
nephroJin07-12 23:42
回复@小绿的薄荷糖: $Actinium(ATNM)$ 好问题.两者并不冲突,因为Actinium的iomab-B不是用来根治难治性AML的.他是为了骨髓移植做准备的.首先咱必须知道AML患者的骨髓里髓系造血祖细胞发生恶性转化和增殖是很难控制的,假如运气好控制住也是复发概率极大,特别是被诊断为难治性AML,虽然Venetoclax联合...查看全文
nephroJin06-26 13:51
回复@JZee: Actinium专注于RDCs我觉得挺好的。毕竟ADCs太拥挤了。Actimab-M在动物试验阶段就没通过,Lintuzumab-Ac225和BC8-I31在early stage有疗效但在临床试验中未达到理想疗效,并且有不良反应和高毒性问题。我觉得在这些失败的管线中Actinium科研团队对靶向性和毒性之间的平衡,试验设计,患者...查看全文
Actinium(ATNM)04-27 05:05
$Actinium(ATNM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-24-036699 Act: 34 Size: 11 MB 网页链接查看全文
小水大雨2019-12-31 00:23
$Actinium(ATNM)$ 长期下跌,周线图显示最近交易量在底部开始增量,空头回补的机率较大,买一点0.23做超短期反弹行情, 支撑0.205, 目标20%+。 看势做事, 严格止损。
个人笔录。查看全文
$Actinium(ATNM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-24-036699 Act: 34 Size: 11 MB 网页链接
$Actinium(ATNM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-24-028038 Act: 34 Size: 18 MB 网页链接
$Actinium(ATNM)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-24-028040 Act: 33 Size: 59 KB 网页链接
$Actinium(ATNM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-000320 Act: 34 Size: 241 KB 网页链接
$Actinium(ATNM)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000312 Act: 33 Size: 1 KB 网页链接
$Actinium(ATNM)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001213900-24-009717 Act: 33 Size: 618 KB 网页链接
$Actinium(ATNM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-005168 Act: 34 Size: 13 KB 网页链接
$Actinium(ATNM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-100091 Size: 5 KB 网页链接
$Actinium(ATNM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-100057 Size: 5 KB 网页链接
$Actinium(ATNM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-100063 Size: 5 KB 网页链接